Otsuka Holdings
4578.T
#645
Rank
ยฃ24.72 B
Marketcap
ยฃ45.90
Share price
-0.53%
Change (1 day)
57.25%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

Earnings for Otsuka Holdings (4578.T)

Earnings in 2024 (TTM): ยฃ0.79 Billion

According to Otsuka Holdings 's latest financial reports the company's current earnings are ยฃ14.47 Billion. In 2023 the company made an earning of ยฃ0.83 Billion a decrease over its 2022 earnings that were of ยฃ1.05 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Otsuka Holdings from 2010 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) ยฃ0.79 B-4.82%
2023 ยฃ0.83 B-20.82%
2022 ยฃ1.05 B-13.04%
2021 ยฃ1.20 B-19.69%
2020 ยฃ1.50 B13.78%
2019 ยฃ1.32 B52.13%
2018 ยฃ0.86 B11.32%
2017 ยฃ0.78 B-36.26%
2016 ยฃ1.22 B31.64%
2015 ยฃ0.93 B
2013 ยฃ1.93 B33.73%
2012 ยฃ1.44 B-4.78%
2011 ยฃ1.52 B46.23%
2010 ยฃ1.03 B